Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells.
about
Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic CellsThe Role of Damage-Associated Molecular Patterns in Human Diseases: Part I - Promoting inflammation and immunityCause and consequences of the activated type I interferon system in SLEAnti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue diseaseThe dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunityDendritic cells in systemic lupus erythematosusTLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice.C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes.Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation.Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosusThe type I interferon system in the etiopathogenesis of autoimmune diseases.Type I interferon and systemic lupus erythematosus.Plasmacytoid dendritic cells in atherosclerosis.Toll-like receptors as therapeutic targets for autoimmune connective tissue diseasesThe complement receptor 3 (CD11b/CD18) agonist Leukadherin-1 suppresses human innate inflammatory signalling.Fueling autoimmunity: type I interferon in autoimmune diseases.Potential role of IFNα in adult lupus.Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning?Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs?Disease mechanisms in rheumatology--tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases.Aberrant B-lymphocyte responses in lupus: inherent or induced and potential therapeutic targets.B-lymphocyte signalling abnormalities and lupus immunopathology.Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.Innate immunity in systemic sclerosis pathogenesis.Plasmacytoid Dendritic Cells: Neglected Regulators of the Immune Response to Staphylococcus aureus.Systemic Lupus Erythematosus--A Disease with A Dysregulated Type I Interferon System.Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation.Antinuclear antibody testing - misunderstood or misbegotten?FcγRIIB prevents inflammatory type I IFN production from plasmacytoid dendritic cells during a viral memory response.Positivity for anti-RNP antibody is a risk factor for adverse effects caused by trimethoprim-sulfamethoxazole, a prophylactic agent for P. jiroveci pneumonia, in patients with connective tissue diseases.Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus.IFN-α production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases.Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors.New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA.Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus.Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype.Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy.Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes.Circulating microRNA expression profiles associated with systemic lupus erythematosus.Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases.
P2860
Q26748941-8023BC21-3F06-42DF-95CB-80A5F71888B8Q26864215-6E012AD6-97D8-4184-88C0-8CABFB6ACFB9Q28075268-317737B7-0D6D-4539-A2A0-53A2708A0E6AQ28290942-46CDF272-1CA2-480C-8000-AC9B8E64D859Q28384138-FB98C058-E916-4D1B-B4F6-1EAB992CC59CQ33941433-A7FC21BA-184C-4968-90F4-1E7B1C97A1DDQ34264928-64CB02A3-1AAC-4CCF-8669-707BDA76D935Q34729450-DA1C2913-FC2D-436D-9294-2F71CBAA37F0Q35334977-8D68C4E6-AEC7-4869-A984-F6552238BCE9Q35512674-35F43EFD-569B-4B57-BE4E-A58213B56B9AQ35514368-36542BF0-ECB6-453B-AD7C-38E615FA5F59Q35549980-F82DB83B-9589-41EE-A4D5-5E3CB01D3678Q36064574-0D244C6F-1A3A-4184-90D5-4C01AB36C3CDQ36940639-57197560-08AD-411F-95F9-DF128A9B12E9Q37190531-445ACA78-62D5-4C55-9A6C-3B43BC0C497EQ37416120-8449A902-5974-412B-B43A-2582CDAB19C1Q37730992-8AD4FD59-D327-4591-BF6F-D47FCDFD5E11Q37814530-9C9F0711-692A-4906-B6C7-5BDF195F752DQ37868069-89A54457-C012-420B-995D-F88A75E626CEQ38070990-0E4FD403-D946-4791-8180-605204D3D7A0Q38108851-DA9329B1-54A5-4D00-AEEF-FD181AC015D9Q38114500-5E2EB8F6-8FFA-49A2-B48A-528F16AAFC6DQ38130904-97019452-3F50-45EE-B401-1277A9528C60Q38161937-D4AA3097-5244-4CA2-824F-BE2C9B447F85Q38218117-041F2A11-C484-42FE-8865-77AB95158456Q38534457-7B8C44EA-A950-4C50-BEC6-E5A9A9355BC1Q38673434-F43B55F0-4DF8-4E64-BAB4-8B2E4CC676BDQ39328604-31BABA3B-2407-4905-8A88-9AB3F5B2DFE9Q39868598-BBDFA619-582F-4D1E-A293-C9B084F48D07Q40291551-24E203EF-1A49-4420-A0DB-A3ECB1525CE5Q41873579-2CFE0A69-68CF-4149-B349-BBCE4409F1AFQ42154442-7A0B3016-8C02-4307-9531-11B13D88131FQ43091811-8E8DFF4C-8BEF-458C-AA5C-3082CC2106D8Q45047946-5AA42ABD-F64E-498D-ADA7-9562DE906706Q45959105-A39B0DAC-8B09-4783-A76D-DC9277334E8EQ48004729-7B771A3B-93F0-4608-B062-CA4FCF6DB28CQ51168774-3ADBE5C1-DA57-45B1-93AA-123C3306D87CQ53471242-B299BCDE-E877-4364-9F1E-5C542C81FCB6Q54272397-E7EB73DD-4297-476A-8930-C4A6271FBA3FQ55383884-0843B547-969D-43B6-BA38-6A1F33385F60
P2860
Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Regulation of the interferon-a ...... plasmacytoid dendritic cells.
@en
Regulation of the interferon-a ...... plasmacytoid dendritic cells.
@nl
type
label
Regulation of the interferon-a ...... plasmacytoid dendritic cells.
@en
Regulation of the interferon-a ...... plasmacytoid dendritic cells.
@nl
prefLabel
Regulation of the interferon-a ...... plasmacytoid dendritic cells.
@en
Regulation of the interferon-a ...... plasmacytoid dendritic cells.
@nl
P2093
P2860
P356
P1476
Regulation of the interferon-a ...... plasmacytoid dendritic cells.
@en
P2093
Doreen Finke
Gunnar V Alm
Johan Rönnelid
Lars Rönnblom
Linda Mathsson
Maija-Leena Eloranta
Tanja Lövgren
P2860
P304
P356
10.1002/ART.24686
P577
2009-08-01T00:00:00Z